• 1. Establishment and implications of a characterization method for magnetic nanoparticle using cell tracking velocimetry and magnetic susceptibility modified solutions
  Huading Zhang,Lee R. Moore,Maciej Zborowski,P. Stephen Williams,Shlomo Margel,Jeffrey J. Chalmers Analyst, 2005,130, 514-527
• 2. Embedding heteroatoms: an effective approach to create porphyrin-based functional materials
  Norihito Fukui,Keisuke Fujimoto,Hideki Yorimitsu,Atsuhiro Osuka Dalton Trans., 2017,46, 13322-13341
• 3. Excellent kinetics of single-phase Gd-doped ceria fuel electrodes in solid oxide cells?
  Andreas Nenning,Manuel Holzmann,Jürgen Fleig,Alexander K. Opitz Mater. Adv., 2021,2, 5422-5431
• 4. Evolution in surface coverage of CH3NH3PbI3?XClXvia heat assisted solvent vapour treatment and their effects on photovoltaic performance of devices
  Dhirendra K. Chaudhary,Pramendra Kumar,Lokendra Kumar RSC Adv., 2016,6, 94731-94738
• 5. Excited state potential energy surfaces and their interactions in FeIVO active sites
  Shaun D. Wong,Edward I. Solomon Dalton Trans., 2014,43, 17567-17577

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Diazinanes Piperazines

Comprehensive Overview of tert-butyl N-(piperazin-2-yl)methylcarbamate (CAS No. 875551-76-1)

tert-butyl N-(piperazin-2-yl)methylcarbamate (CAS No. 875551-76-1) is a specialized organic compound widely utilized in pharmaceutical research and fine chemical synthesis. This compound, often referred to by its systematic name or CAS number, plays a pivotal role in the development of novel drug candidates, particularly in the fields of central nervous system (CNS) therapeutics and enzyme inhibitors. Its unique structural features, including the piperazine ring and tert-butyl carbamate group, make it a versatile intermediate for medicinal chemistry applications.

In recent years, the demand for tert-butyl N-(piperazin-2-yl)methylcarbamate has surged due to its relevance in addressing modern healthcare challenges. Researchers are increasingly exploring its potential in neurodegenerative disease treatments, such as Alzheimer's and Parkinson's, where modulating neurotransmitter systems is critical. Additionally, its application in cancer drug discovery has gained traction, as piperazine derivatives are known to exhibit kinase inhibitory activity. These trends align with frequent search queries like "piperazine derivatives in drug development" and "CAS 875551-76-1 applications," reflecting growing scientific interest.

The synthesis of tert-butyl N-(piperazin-2-yl)methylcarbamate typically involves multi-step organic reactions, including Boc protection strategies and reductive amination processes. Its purity and stability are paramount for pharmaceutical use, driving advancements in analytical techniques such as HPLC and LC-MS for quality control. Industry professionals often search for "synthesis optimization of CAS 875551-76-1" or "Boc-protected piperazine derivatives," underscoring the need for efficient production methods.

From a regulatory perspective, tert-butyl N-(piperazin-2-yl)methylcarbamate complies with global standards for research chemicals, with no restrictions under major chemical control frameworks. This makes it accessible for academic and industrial laboratories focusing on peptide mimetics or small molecule drug design. Environmental considerations are also addressed through green chemistry approaches, responding to queries like "sustainable synthesis of piperazine intermediates."

Future prospects for this compound include its integration into combinatorial chemistry libraries and high-throughput screening platforms. As precision medicine advances, customized modifications of the piperazine scaffold may unlock new therapeutic avenues. The compound's relevance in GPCR-targeted drugs (G protein-coupled receptors) further positions it at the forefront of biopharmaceutical innovation, matching trending searches about "next-generation drug scaffolds."

In summary, tert-butyl N-(piperazin-2-yl)methylcarbamate (CAS No. 875551-76-1) represents a critical building block in contemporary drug discovery. Its adaptability to diverse medicinal chemistry applications and alignment with cutting-edge research priorities ensure its continued importance in scientific and industrial contexts. For researchers seeking reliable data, this compound exemplifies the intersection of chemical innovation and therapeutic potential.

• 255735-88-7(tert-butyl N-(2-aminopropyl)carbamate)
• 149632-73-5(Tert-Butyl (1-aminopropan-2-yl)carbamate)
• 1159825-34-9(tert-butyl 1,3,4,6,7,8,9,9a-octahydropyrazino[1,2-a]pyrazine-2-carboxylate)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)